Literature DB >> 14684232

Phenytoin and phenobarbital stable isotope studies in neonates.

Saleem I Malik1, Michael J Painter, Raman Venkataramanan, John D Alvin.   

Abstract

A pharmacokinetic study of phenytoin and phenobarbital with nonradioactive isotopes was performed in nine neonates in an intensive care unit setting. A single-pulse dose of either labeled phenobarbital (1,3-(15)N, 2-(13)C) or labeled phenytoin (2-(13)C, 1, 3-(15)N) was administered to neonates who manifested gestation between 25 and 40 weeks and were receiving maintenance medication. Blood samples were collected at fixed intervals, and with a computerized gas chromatography mass spectrometry system, plasma concentrations of the labeled and unlabeled drug in relation to time administered were obtained. According to the calculations obtained from labeled analogue, several kinetic characteristics related to drug absorption, clearance, and elimination were determined. The use of a nonradioactive labeled isotope overcomes the limitations of conventional pharmacokinetic methodology and can be specifically useful in neonates and infants in whom volumes of distribution are rapidly changing and steady state is not achieved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684232     DOI: 10.1016/s0887-8994(03)00304-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

Review 1.  Applications of stable isotopes in clinical pharmacology.

Authors:  Reinout C A Schellekens; Frans Stellaard; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

2.  Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant mice.

Authors:  Ivan Weinsanto; Alexis Laux-Biehlmann; Jinane Mouheiche; Tando Maduna; François Delalande; Virginie Chavant; Florian Gabel; Pascal Darbon; Alexandre Charlet; Pierrick Poisbeau; Marc Lamshöft; Alain Van Dorsselaer; Sarah Cianferani; Marie-Odile Parat; Yannick Goumon
Journal:  Br J Pharmacol       Date:  2018-08-31       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.